Autoimmune And Inflammation Inflammation

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
Inflammation Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Inflammation Projects
--Alcon Inc
--A-VIRAL ASA
--AsiaPharm Group Ltd.
--Array BioPharma Inc
--Biogen Idec Inc
--Axcan Pharma Inc.
--Cellerix
--Celgene Corporation
--Critical Therapeutics Inc
--Ception Therapeutics
--Galenica Ltd.
--DAIICHI SANKYO COMPANY, LIMITED
--MIKA Pharma GmbH
--Genentech Inc
--Reata Pharmaceuticals, Inc.
--Mistral Pharma Inc.
--SantoSolve AS
--Roche Holdings Ltd
--Wyeth
--Tragara Pharmaceuticals, Inc.

--Top Companies in early stage Inflammation Projects
--AstraZeneca Plc
--Arriva Pharmaceuticals, Inc
--Biotie Therapies Corp.
--BioLineRx, Ltd.
--Clavis Pharma ASA
--Celgene Corporation
--elbion NV
--Compugen Ltd
--Genpat77 Pharmacogenetics AG
--Eli Lilly & Co
--Medical Therapies Ltd
--GlycoMimetics, Inc.
--Nereus Pharmaceuticals, Inc.
--Merckle Group
--Pharmacopeia, Inc.
--Novartis AG
--Seikagaku Corporation
--Schering-Plough Corp
--Zydus Cadila Healthcare Limited
--Vascular Biogenics Ltd.

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Approved Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View